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Abstract
Background Women with a family history of breast cancer may
be at higher risk for breast cancer, but few previous studies
evaluating diet and breast cancer have focused on such women.
The objective of the present study was to determine whether
diet, a modifiable risk factor, is related to breast density among
women at high genetic risk for breast cancer.
Methods Women with at least one first-degree or second-
degree relative with breast cancer or ovarian cancer
participating in the Fox Chase Cancer Center Family Risk
Assessment Program completed health history and food
frequency questionnaires and received standard screening
mammograms. Cranial–caudal mammographic images were
classified into the four Breast Imaging Reporting and Data
System categories ranging from 'entirely fatty' to 'extremely
dense'. Logistic regression analysis using proportional odds
models for polychotomous outcomes provided estimates of
odds ratios for having a higher category versus a lower category
of breast density.
Results Among 157 high-risk women, breast density was
inversely associated with vitamin D intake (odds ratio for third
tertile versus first tertile, 0.5; 95% confidence interval, 0.2–1.0).
In contrast, intakes above the median level for protein (odds
ratio, 3.0; 95% confidence interval, 1.3–6.9) and above the
median level for animal protein (odds ratio, 4.3; 95% confidence
interval, 1.8–10.3) were associated with higher breast density,
but only among women whose family history did not reflect a
known familial cancer syndrome or a breast cancer
predisposition gene.
Conclusion For women with a strong family history that was not
associated with known cancer syndromes, dietary factors may
be associated with breast density, a strong predictor of breast
cancer risk. Since women with strong family history are often
very motivated to change their lifestyle habits, further studies are
needed to confirm whether changes in diet will change the
breast density and the subsequent onset of breast cancer in
these women.
Introduction
Women with a family history of breast cancer may be at higher
genetic risk for breast cancer because of either recognized
deleterious mutations or as yet unidentified low-penetrance
alleles. Such women are likely to be especially motivated to
modify their lifestyle to reduce their risk for breast cancer. Diet
modification is one possible strategy, but few previous studies
evaluating diet and breast cancer have focused on women at
high genetic risk [1,2].
Breast density, the percentage of total breast area with a mam-
mographically dense appearance, is an informative marker for
breast cancer risk because of its strong association with
breast cancer [3-5]. Breast density has been shown to predict
risk among women with a genetic predisposition for breast
cancer [6], including women carrying BRCA1 or BRCA2
mutations [7]. Among the few studies on diet and breast den-
sity [8-16], only one specifically included women with a family
history of the disease [17]. The objective of the present study
was to evaluate associations between dietary intake and
breast density among women at potentially high genetic risk
for breast cancer. We focused on dietary factors associated
with breast density in previous studies conducted among
average-risk samples [8-10,12-15,18], as well as on sus-
pected risk factors or protective factors for breast cancer [19]
FRAP = Family Risk Assessment Program.Breast Cancer Research    Vol 9 No 5    Tseng et al.
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Materials and methods
Study population
The study sample was drawn from 1,313 women enrolled in
the Family Risk Assessment Program (FRAP) at Fox Chase
Cancer Center in Philadelphia from September 1991 to April
2001. The FRAP was initiated in 1991 to offer education and
preventive interventions, and to serve as a research base for
studying gene–environment interactions in breast cancer and
ovarian cancer. Women are eligible for the FRAP if they have
at least one first-degree or second-degree relative with breast
cancer or ovarian cancer. Recruitment strategies include refer-
rals from breast cancer patients or ovarian cancer patients at
Fox Chase Cancer Center, radio and newspaper advertise-
ments, and physician referrals and self-referrals.
FRAP participants were eligible for the breast density study if
they were at least 40 years old. Exclusion criteria included a
history of breast augmentation or reduction, a history of pro-
phylactic mastectomy, a history of cancer except non-
melanoma skin cancer, a current or planned pregnancy,
current breastfeeding, a weight change of at least 20 lb during
the past year, a substantial change in diet over the past year,
or no mammogram planned within the study timeframe. Of 510
potentially eligible women invited to participate, 177 women
agreed, 153 women declined, 125 women could not be con-
tacted, and 55 women were subsequently found to be ineligi-
ble. An additional 13 women were excluded – because their
questionnaires were inadequately completed (n = 7), because
their mammograms could not be obtained (n = 5), or because
they reported an energy intake >3,500 kcal/day (n = 1) – leav-
ing 164 for inclusion in analyses. A comparison of the women
included in the analysis with remaining women in the partici-
pant pool showed no significant differences in age, ethnicity,
level of education, body mass index, dietary intake, or smoking
status, but participants were more likely than nonparticipants
to have a first-degree relative with breast cancer (74% versus
61%, P = 0.008).
Data collection
Upon enrollment into the FRAP, women completed a health
history questionnaire for baseline information on sociodemo-
graphic characteristics, family history of cancer, and reproduc-
tive factors, including age at menarche. In 1996, detailed
questions on pregnancy history were added to the baseline
questionnaire. Each year after their baseline, the FRAP partic-
ipants were also asked to complete a follow-up questionnaire
for updated information on pregnancies and new occurrences
of cancer in the family.
Pedigrees provided at baseline and updated annually were
reviewed by a team of genetic counselors, and were classified
as reflecting one of four categories: (1) sporadic, indicated by
a single occurrence of cancer diagnosed at any age occurring
on one side of the family only; (2) familial, reflecting a pattern
of cancers seen in at least one generation but not fitting a
known cancer family syndrome; (3) putative hereditary, fitting
a hereditary pattern of cancer inheritance or known cancer
family syndrome not yet confirmed by genetic testing; or (4)
confirmed hereditary, representing inheritance of a cancer pre-
disposition gene confirmed through genetic testing performed
on the proband or on a relative. Women in the putative and
confirmed hereditary categories (categories (3) and (4)) were
grouped together in analyses to reflect the presence of a can-
cer family syndrome whether based on pedigree analysis or
genetic testing. Such pedigrees primarily reflected the pres-
ence of a BRCA1 or BRCA2 mutation but also included other
cancer family syndromes such as Li–Fraumeni syndrome or
Cowden's disease.
All FRAP participants were also asked to complete the Har-
vard Diet Assessment Form [20] for information on intake fre-
quencies over the previous year of 126 food items and of
vitamin and mineral supplement use. The Diet Assessment
Form was found to be reasonably valid in a sociodemographi-
cally similar sample of women [21].
Participants in the breast density study received a standard
screening mammogram at Fox Chase Cancer Center, were
measured for weight and height, completed another Diet
Assessment Form for their dietary intake for the year previous
to the study mammogram, and completed an additional ques-
tionnaire for updated information on smoking habits, physical
activity, and reproductive factors including pregnancies,
breastfeeding, use of hormonal contraceptives or hormone
replacement medicine, age at first live birth, and menopausal
status. Menopausal status was determined based on whether
the participant reported having had a menstrual period within
the last year. The study protocol was approved by the Institu-
tional Review Board of the Fox Chase Cancer Center (IRB
protocol number 00-803), and all participants gave their writ-
ten informed consent to participate in the study.
Breast density assessment
All participants received a standard screening mammogram.
For premenopausal women, all efforts were made to schedule
mammograms during the follicular phase of each woman's
menstrual cycle, when breast tissue is less radiographically
dense [22]. Breast density was assessed by the study radiol-
ogist (KAE), who was blinded to the identity and other per-
sonal characteristics of study subjects, using the Breast
Imaging Reporting and Data System: 1 = entirely fatty, 2 =
scattered fibroglandular tissue, 3 = heterogeneously dense,
and 4 = extremely dense [23].
Results presented below are based on radiological classifica-
tions for the cranial–caudal view of a randomly selected side.
Consistent with previous work [24], however, left-side and
right-side assessments were highly correlated (r = 0.97) in the
172 women with mammographic data, and assessments
between left and right sides agreed in all but 10 (6%) women.Available online http://breast-cancer-research.com/content/9/5/R72
Page 3 of 9
(page number not for citation purposes)
In reproducibility assessments conducted in a randomly
selected set of 52 images, we calculated a kappa statistic of
0.97 for the left-side images and 0.89 for the right-side
images.
Data analysis
We used logistic regression analysis for polychotomous out-
comes using proportional odds models [25] to estimate the
odds ratios. All log odds can be interpreted as the odds for a
woman having a higher category versus a lower category for
breast density [25]. Dietary factors of interest were calories,
total fat and saturated fat, cholesterol, protein, animal protein,
carbohydrates, dietary fiber, carotene, folate, calcium, vitamin
D, and vitamin E, as well as foods and food groups including
meats, fruits and vegetables, tofu, and alcoholic beverages.
Nutrient values included both dietary and supplemental
sources and were energy-adjusted using the residual method
[26]. The odds ratios were estimated for upper tertiles versus
lower tertiles of intake; but for infrequently consumed items
such as tofu, estimates were for consumption versus noncon-
sumption. Variables evaluated as potential confounders
included age, body mass index, level of education (college
graduate or not), age at menarche, number of live births, age
at first live birth, ever breastfed, menopausal status, ever use
of hormonal contraceptives, ever use of hormone replacement
therapy, physical activity (hours per week), smoking status
(never, former, current), family history category (sporadic,
familial, hereditary), and energy intake. Too few women
reported current use of either hormonal contraceptives or hor-
mone replacement therapy to examine their associations with
breast density separately from previous use.
Final multivariate models included 157 women with complete
covariate data and adjusted for age, body mass index, caloric
intake, age at menarche, menopausal status, history of hor-
mone replacement therapy use, and family history category.
Results were not materially different when we excluded six
women who reported current use of either raloxifene or
tamoxifen. Because detailed questions on pregnancy history
were not included in the baseline questionnaire until 1996, a
large number of women had incomplete data on number of live
births and age at first live birth. We therefore ran separate
models to examine potential confounding by these factors in
the subset of women with complete data for these variables.
The P values for a linear trend were obtained for each dietary
variable using an ordinal variable representing the scaled
median value for each tertile. We examined effect modification
by menopausal status using stratified models with each dietary
variable dichotomized at the median. The P values for interac-
tion were obtained from a model including all women, with a
dietary variable x menopausal status interaction term. Because
we observed no significant differences in effect estimates by
menopausal status, results presented are for premenopausal
women and postmenopausal women combined. We used a
similar strategy to examine effect modification by family history
category, comparing women with a hereditary family history of
cancer with women without such a family history. We com-
bined women with sporadic breast cancer family histories and
women with familial breast cancer family histories because
there were too few women (n = 32) with only a family history
of sporadic breast cancer. In contrast to women with a hered-
itary family history of cancer based on pedigrees or genetic
testing representing a stronger genetic predisposition to
breast cancer, women with sporadic breast cancer family his-
tories and familial breast cancer family histories may represent
women with lower-penetrance susceptibility genes that have
not yet been identified, but that still places them at higher
genetic risk.
Results
The 157 women in the analysis had a mean ± standard devia-
tion age of 50 ± 8 years; 96% were white, and 73% had at
least a college degree. Among the mammographic images
included in the analyses, 12.7% (n = 20) were classified as
entirely fatty, 28.0% (n = 44) as having scattered fibroglandu-
lar tissue, 34.4% (n = 54) as heterogeneously dense, and
24.8% (n = 39) as extremely dense. Having denser breasts
was associated with younger age, lower body mass index,
older age at menarche, smaller number of live births, older age
at first live birth, and a history of having used hormone replace-
ment therapy (Table 1). Menopausal status was inversely
associated with breast density, but not significantly after
adjustment for age. Level of education, current smoking, and a
hereditary family history of breast cancer showed nonsignifi-
cant positive associations with breast density. We observed
no associations with breast density for breastfeeding, history
of oral contraceptive use, or physical activity.
Breast density was significantly inversely associated with
intake of vitamin D (Table 2); women in the highest tertile of
vitamin D intake were one-half as likely to have higher breast
density as women in the lowest tertile (odds ratio, 0.5; 95%
confidence interval, 0.2–1.0). We also observed a suggestive
but nonsignificant inverse association for folate (odds ratio,
0.5 for highest tertile versus lowest tertile; 95% confidence
interval, 0.2–1.1; trend P  = 0.09). Breast density was not
associated with any other nutrients of interest (Table 2) or with
any foods of interest (meats, fruits and vegetables, tofu, alco-
holic beverages – results not shown) among all participants
combined.
In stratified analyses, we found evidence for effect modifica-
tion by family history category (Table 3). Whereas protein
intake and animal protein intake were not significantly associ-
ated with breast density among women with a hereditary pat-
tern of family history of breast cancer, these nutrients were
positively associated with breast density among women with
sporadic or other familial histories. The odds ratios for women
with intake above the median were 3.0 (95% confidence inter-Breast Cancer Research    Vol 9 No 5    Tseng et al.
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val, 1.3–6.9) and 4.3 (95% confidence interval, 1.8–10.3) for
protein and animal protein, respectively. These results were
not meaningfully different when we controlled for number of
live births and age at first live birth in the 120 women with com-
plete data (results not shown).
Discussion
In this broad exploration of dietary factors, we found that only
vitamin D intake was inversely associated with breast density
in a sample of women enrolled in a high-risk program for breast
cancer. Protein and animal protein were positively associated
with breast density, but only among women not classified as
having the hereditary familial cancer patterns.
Our results are consistent with recent work showing an
inverse association between vitamin D and breast density
[14,18], as well as studies suggesting a protective effect of
vitamin D against breast cancer [27]. A previous study
observed an inverse association of vitamin D with breast den-
sity only among premenopausal women [18], and primarily
among premenopausal women with higher levels of insulin-like
growth factor 1 or of insulin-like growth factor binding protein
3 [28]. In the present study, we saw no difference in effect by
menopausal status. Vitamin D may lower breast density
through the antiproliferative and proapoptic effects of its bio-
logically active form, 1,25-dihydroxyvitamin D, or through mod-
ulation of the immune system [27,29]. Notably, most tissues
and cells, including those in the breast, have vitamin D recep-
tors and are also able to metabolize circulating 25-hydroxyvita-
min D to 1,25-dihydroxyvitamin D, allowing for local, cellular
effects in the breast tissue [29].
Whether the inverse association we observed is truly attribut-
able to a protective effect of dietary vitamin D, however,
remains unclear. We did not assess sunlight exposure,
another important determinant of vitamin D status, nor did we
have serum samples available to assess the relationship of
breast density either with 25-hydroxyvitamin D as an indicator
Table 1
Characteristics of women by breast density category, and odds ratios for association with denser breast category (n = 157)
Characteristic Entirely fatty (n = 20) Heterogeneously
dense (n = 44)
Scattered
fibroglandular tissue
(n = 54)
Extremely dense
(n = 39)
Age-adjusted odds ratio
(95% confidence interval)a
Age (years) 54.1 ± 1.0 53.9 ± 0.9 48.7 ± 0.6 47.4 ± 0.7 0.4 (0.3–0.6)b
College graduate (%)c 55 72 72 84 1.5 (0.8–3.0)
Body mass index (kg/m2) 33.3 ± 7.1 28.3 ± 6.1 24.8 ± 4.4 23.8 ± 3.0 0.8 (0.8–0.9)
Age at menarche (years) 12.4 ± 1.3 12.3 ± 1.3 12.5 ± 1.4 13.1 ± 1.8 1.3 (1.1–1.6)
Number of live birthsc 3.1 ± 1.4 2.5 ± 1.6 2.6 ± 0.9 1.9 ± 1.0 0.8 (0.6–1.0)
Age at first birth (years)c 23.7 ± 5.9 25.6 ± 4.1 27.4 ± 5.8 29.5 ± 5.1 1.1 (1.0–1.2)
Ever breastfedc 30 72 63 75 1.0 (0.4–2.7)
Postmenopausal 65 66 33 28 0.5 (0.3–1.2)
Ever used hormonal 
contraceptives
45 41 63 37 0.8 (0.5–1.4)
Ever used hormone 
replacement medicined
85 45 56 36 0.4 (0.2–1.0)
Weekly physical activity 
(hours)
2.9 ± 2.9 3.6 ± 3.0 3.5 ± 2.9 2.9 ± 2.5 1.0 (0.8–1.1)
Smoking status
 Never smoked 50 49 57 61 1.0
 Former smoker 45 49 39 26 0.6 (0.3–1.1)
 Current smoker 5 2 4 13 2.0 (0.5–7.6)
Family history of breast cancer
 Negative or sporadic 15 30 22 10 1.0
 Familial 35 45 33 33 1.3 (0.6–2.9)
 Hereditary 50 25 44 56 1.8 (0.8–4.0)
Characteristics data presented as the mean ± standard deviation or as the percentage. aOdds ratios adjusted for age except for the age variable. 
bOdds ratio for 10-year age increment. c Because of missing responses, analyses included only 155 women for education level, 125 women for 
number of live births, 120 parous women for age at first live birth, and 74 parous women for breastfeeding. dAnalysis conducted among 70 
postmenopausal women.Available online http://breast-cancer-research.com/content/9/5/R72
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Table 2
Adjusted odds ratiosa and 95% confidence intervals by tertile of nutrient intake (n = 157)
Nutrient Tertile 1 Tertile 2 Tertile 3 Trend P valueb
Energy (kcal)
 Median per day 1,357 1,807 2,444
 Odds ratio (95% confidence interval) 1.0 1.6 (0.7–3.3) 0.9 (0.4–2.0) 0.79
Total fat (g)
 Median per day 55.5 60.8 73.1
 Odds ratio (95% confidence interval) 1.0 1.9 (0.9–4.2) 1.5 (0.7–3.1) 0.33
Saturated fat (g)
 Median per day 18.7 22.4 27.2
 Odds ratio (95% confidence interval) 1.0 0.9 (0.4–1.9) 0.9 (0.4–1.9) 0.70
Cholesterol (mg)
 Median per day 200 221 305
 Odds ratio (95% confidence interval) 1.0 1.6 (0.7–3.6) 1.2 (0.5–2.7) 0.72
Protein (g)
 Median per day 76.0 76.0 93.4
 Odds ratio (95% confidence interval) 1.0 1.0 (0.5–2.2) 0.9 (0.4–2.0) 0.87
Animal protein (g)
 Median per day 49.0 51.0 68.4
 Odds ratio (95% confidence interval) 1.0 1.0 (0.5–2.3) 1.1 (0.5–2.3) 0.87
Carbohydrates (g)
 Median per day 174.0 228.5 304.6
 Odds ratio (95% confidence interval) 1.0 0.7 (0.3–1.5) 0.9 (0.4–1.9) 0.79
Fiber (mg)
 Median per day 12.4 18.5 27.2
 Odds ratio (95% confidence interval) 1.0 0.5 (0.2–1.1) 0.7 (0.3–1.5) 0.57
Carotene (IU)
 Median per day 4,969 8,621 17,714
 Odds ratio (95% confidence interval) 1.0 0.5 (0.3–1.2) 0.7 (0.3–1.5) 0.51
Folate (mcg)
 Median per day 344 650 943
 Odds ratio (95% confidence interval) 1.0 0.7 (0.3–1.5) 0.5 (0.2–1.1) 0.09
Calcium (mg)
 Median per day 766 1,271 1,871
 Odds ratio (95% confidence interval) 1.0 1.4 (0.6–3.0) 1.0 (0.5–2.1) 0.83
Vitamin D (IU)
 Median per day 164 463 737
 Odds ratio (95% confidence interval) 1.0 0.7 (0.3–1.5) 0.5 (0.2–1.0) 0.05
Vitamin E (mg)
 Median per day 6.8 40.9 436.4
 Odds ratio (95% confidence interval) 1.0 0.4 (0.2–1.0) 0.6 (0.3–1.2) 0.37
aModels adjusted for age, body mass index, caloric intake, age at menarche, menopausal status, hormone therapy use, and family history category. 
bP value for trend obtained by including in the model a variable representing the median value for each tertile.Breast Cancer Research    Vol 9 No 5    Tseng et al.
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of vitamin D status or with 1,25-dihydroxyvitamin D. Of two
previous studies that examined 25-hydroxyvitamin D in relation
to breast density, one study saw a protective effect [30] while
the other study did not [30]. In additional analyses we explored
whether breast density might be more strongly associated
with major dietary sources of vitamin D, such as dairy or fish,
but we observed no clear associations (results not shown).
Our results are also consistent with previous studies that
found positive associations of breast density with protein or
meat intake [11,12,31]. Animal protein intake may increase
breast density by increasing circulating levels of insulin-like
growth factor-1 [32,33], which has been linked to higher
breast density [34] and higher breast cancer risk [35-37]
among premenopausal women. In the present study, the asso-
ciations for protein and animal protein were limited to women
without a hereditary family history of breast cancer. Classifica-
tion of a hereditary family history of breast cancer in our sam-
ple primarily represented the presence of a BRCA1 mutation
or a BRCA2 mutation. While this effect modification may be a
chance finding, it may also suggest that, in such women, the
same genetic factors that predispose to higher breast cancer
risk increase the risk for dense breasts as well [38], and that
genetic effects can overwhelm the effects of reduced dietary
protein. For example, if BRCA1 exerts downstream effects on
transcription, expression, or circulating levels of members of
the insulin-like growth factor system as suggested by recent
work [39-41], then breast tissue may be denser among
BRCA1 mutation carriers [38] regardless of their level of pro-
tein intake.
Other dietary factors may affect breast density by affecting
estrogen levels or by directly affecting breast tissue morphol-
ogy [8,10,14] – but only limited, indirect evidence exists to
support these mechanisms, and previous study findings with
respect to other dietary factors have been inconsistent. In
cross-sectional analyses, breast density has been both posi-
tively associated [8,9,11,31] and inversely associated [13,17]
with total and saturated fat intake. Findings for soy and isofla-
vones have been similarly mixed [13,15,16,42,43]. Among
other nutrients, higher breast density has been related to alco-
hol intake [17,44,45] and inversely related to carotenoid, fiber,
and calcium [8,9,14,18,45,46].
Previous studies have observed a protective effect of folate
against breast cancer [47], possibly because of its role in DNA
methylation, synthesis, and repair [48], although breast den-
sity studies have not supported this [17,45]. In our sample we
observed only a suggestive, nonsignificant inverse associa-
tion. A protective effect of folate may be more pronounced
among women with high alcohol intake [47], and alcohol
intake in our sample was generally low (median 1.1 g/day alco-
hol). While too few women reported even moderate alcohol
intake to examine folate in this group separately, when we
excluded nine women with alcohol intake >15 g/day the
inverse association for folate was slightly attenuated (trend P
= 0.27).
Difficulties in assessing breast density may contribute to the
inconsistent results of studies on diet and breast density. Most
studies, including the current analysis, defined breast density
in categories of percentage density. While the method is more
subjective than a computer-assisted method [49], the Breast
Imaging Reporting and Data System categories are neverthe-
less a strong predictor of breast cancer risk [50]. Some work-
ers have suggested that absolute size of the area of density is
Table 3
Adjusted odds ratiosa and 95% confidence intervals for dichotomized dietary intakeb by family history category
Sporadic or familial family history (n = 90) Hereditary family history (n = 67)
Median (g) Odds ratio (95% 
confidence interval)
Median (g) Odds ratio (95% 
confidence interval)
Protein
 Low 76.2 1.0 77.6 1.0
 High 93.5 3.0 (1.3–6.9) 91.0 0.4 (0.1–1.4)
 P value for interactionc <0.001
Animal protein
 Low 51.6 1.0 49.0 1.0
 High 66.4 4.3 (1.8–10.3) 69.6 0.5 (0.1–1.5)
 P value for interaction <0.001
aModels adjusted for age, body mass index, caloric intake, age at menarche, menopausal status, hormone therapy use, and vitamin D intake. 
bDichotomized at median value. cP value for interaction was obtained by including in the model of a dichotomized dietary variable x family history 
category interaction term.Available online http://breast-cancer-research.com/content/9/5/R72
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the more relevant measure [51], but only four previous studies
presented results for dense area size [11,15,16,42] – three of
which focused specifically on soy or isoflavones [15,16,42].
The relevant time period of exposure is also unclear. Women
randomized to a low-fat, high-carbohydrate diet for 2 years as
part of the Canadian Diet and Breast Cancer Prevention Study
Group experienced a greater decrease in area of breast den-
sity relative to a nonintervention group [10,11], suggesting
that recent, relatively short-term dietary exposures can affect
breast density and possibly breast cancer risk, at least in pre-
menopausal women or perimenopausal women. In contrast, a
2-year soy intervention had no effect on breast density change
over time, although soy consumption in early life and adult-
hood did appear to influence density change [16].
A limitation of the present study is its relatively small sample
size, which limited our ability to detect significant associations
and effect modification by menopausal status. Our sample is
unique, however, in that all women had a family history of
breast cancer. Moreover, over 40% of them had a family his-
tory indicating the presence of a high-penetrance cancer pre-
disposition gene, or had been tested to confirm it.
Examining only the recent diet may additionally have limited
our ability to evaluate the role of dietary intake in relation to
breast density. Findings were not different when we used the
average value of dietary intake reported at enrollment into the
FRAP and that reported for the current breast density study,
with a median time interval between the two administrations of
4.5 years, but no other dietary information was available to
assess effects of longer-term dietary intake on breast density.
Data were incomplete for the number of live births and for age
at first live birth; but despite their significant associations with
breast density, these two variables were not important con-
founders among the 120 women not missing this information.
Our findings may be biased if a woman's knowledge of her
breast density, or some characteristic related to her breast
density, influenced her reporting of her dietary intake, or
changed her intake so that her current report was not reflective
of her long-term diet. For example, women with higher breast
density may have been more likely to perceive themselves at
higher risk for breast cancer and to modify their diets
accordingly. We saw no differences, however, in either breast
density or dietary intake by perception of risk for breast cancer
reported at baseline (results not shown).
Because of the large number of dietary factors explored in this
analysis, our findings should be interpreted with caution, war-
rant further investigation into the etiologic mechanism and
warrant confirmation in larger hypothesis-based and pathway-
based studies.
Finally, our findings may be limited in their ability to be gener-
alized to other populations. Participants were drawn from par-
ticipants in a high-risk program, and, even among these
women, those with a lesser family history of breast cancer
were underrepresented in our sample. Nevertheless, the avail-
ability of detailed pedigrees is a significant strength of the
study as it allowed us to classify women on the basis of their
family history of breast cancer in more detail than has been
conducted previously, and hence to distinguish women at the
highest genetic risk for breast cancer. Our study offers sug-
gestive findings that should be confirmed in a larger sample
representing a range of genetic and familial risk for breast can-
cer, in order to clarify the extent to which diet differences might
be related to breast density, and whether effects differ by
genetic susceptibility. Future studies might extend these find-
ings to see whether changes in dietary intake would be asso-
ciated with a change in breast density and a subsequent
change in breast cancer risk.
Conclusion
In summary, in the present broad exploration of dietary factors
in women enrolled in a high-risk program for breast cancer, we
found that only vitamin D intake was inversely associated with
breast density. Protein and animal protein intake were posi-
tively associated with breast density, but only among women
without a hereditary family history of breast cancer. Our latter,
tentative finding suggests that some dietary modification strat-
egies may be more effective in reducing breast density and
hence breast cancer risk in women with a family history of
breast cancer suggestive of lower-penetrance susceptibility
genes, but this requires confirmation in a larger sample repre-
senting a range of genetic risks for breast cancer.
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